Abstract:Background: Evidence-based treatment decisions in medicine are made founded on population-level evidence obtained during randomized clinical trials. In an era of personalized medicine, these decisions should be based on the predicted benefit of a treatment on a patient-level. Survival prediction models play a central role as they incorporate the time-to-event and censoring. In medical applications uncertainty is critical especially when treatments differ in their side effect profiles or costs. Additionally, models must be adapted to local populations without diminishing performance and often without the original training data available due to privacy concern. Both points are supported by Bayesian models-yet they are rarely used. The aim of this work is to evaluate Bayesian parametric survival models on public datasets including cardiology, infectious diseases, and oncology. Materials and methods: Bayesian parametric survival models based on the Exponential and Weibull distribution were implemented as a Python package. A linear combination and a neural network were used for predicting the parameters of the distributions. A superiority design was used to assess whether Bayesian models are better than commonly used models such as Cox Proportional Hazards, Random Survival Forest, and Neural Network-based Cox Proportional Hazards. In a secondary analysis, overfitting was compared between these models. An equivalence design was used to assess whether the prediction performance of Bayesian models after model updating using Bayes rule is equivalent to retraining on the full dataset. Results: In this study, we found that Bayesian parametric survival models perform as good as state-of-the art models while requiring less hyperparameters to be tuned and providing a measure of the uncertainty of the predictions. In addition, these models were less prone to overfitting. Furthermore, we show that updating these models using Bayes rule yields equivalent performance compared to models trained on combined original and new datasets. Conclusions: Bayesian parametric survival models are non-inferior to conventional survival models while requiring less hyperparameter tuning, being less prone to overfitting, and allowing model updating using Bayes rule. Further, the Bayesian models provide a measure of the uncertainty on the statistical inference, and, in particular, on the prediction.

Neural interval-censored survival regression with feature selection

Unbiased Prediction and Feature Selection in High-Dimensional Survival Regression

Improved nonparametric survival prediction using CoxPH, Random Survival Forest & DeepHit Neural Network

Neural topic models with survival supervision: Jointly predicting time-to-event outcomes and learning how clinical features relate

Neural Fine-Gray: Monotonic neural networks for competing risks

Feature Selection for Survival Analysis with Competing Risks using Deep Learning

Case-Base Neural Networks: survival analysis with time-varying, higher-order interactions

Using Geographic Location-based Public Health Features in Survival Analysis

A Simulation Study to Compare the Predictive Performance of Survival Neural Networks with Cox Models for Clinical Trial Data

High‐dimensional feature screening for nonlinear associations with survival outcome using restricted mean survival time

Bayesian variable selection in joint modeling of longitudinal data and interval-censored failure time data

deepAFT: A nonlinear accelerated failure time model with artificial neural network

α-KIDS: A novel feature evaluation in the ultrahigh-dimensional right-censored setting, with application to Head and Neck Cancer

Bayesian parametric models for survival prediction in medical applications

Time-to-event prediction using survival analysis methods for Alzheimer's disease progression

Bayesian Variable Selection for Parametric Survival Model with Applications to Cancer Omics Data

SurvCORN: Survival Analysis with Conditional Ordinal Ranking Neural Network

A network-constrain Weibull AFT model for biomarkers discovery

Gradient-induced variable selection in reproducing kernel Hilbert space for survival analysis

Penalized Bayesian forward continuation ratio model with application to high-dimensional data with discrete survival outcomes